Combination of the deacetylase inhibitor panobinostat and the multi-kinase inhibitor sorafenib for the treatment of metastatic hepatocellular carcinoma - review of the underlying molecular mechanisms and first case report.
about
Minnelide, a novel drug for pancreatic and liver cancerSorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cellsEndoplasmic reticulum stress plays a pivotal role in cell death mediated by the pan-deacetylase inhibitor panobinostat in human hepatocellular cancer cells.Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.Quantification of dynamic contrast-enhanced ultrasound in HCC: prediction of response to a new combination therapy of sorafenib and panobinostat in advanced hepatocellular carcinoma.Profile of panobinostat and its potential for treatment in solid tumors: an update.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine.The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway.Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma.Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells.
P2860
Q27693346-D057C13D-2215-4BA8-9FC6-C695C511F0FDQ28533484-011BBB51-AB63-4405-A9CF-767DCC7D990FQ30455973-7CE3AC86-1E1E-4EDB-BE44-8F19E638A28DQ33744900-734F4DCA-BFE2-4EAE-9B0D-48C5F8C2D9C5Q34401887-AD5112A6-CECD-4FAD-AF46-2830FF9CDF8AQ35979637-3869720A-66ED-4B28-B6F6-CE1FAAFE6306Q37324186-47E53C9A-78D1-4FC9-AEB3-AD5E663E04BBQ38635603-BA1D6B23-E190-4D15-A5D9-C85377724D29Q38811331-7315CA6F-3200-4AAA-A336-2A2FF9097282Q39038662-492ED51C-46A6-45C4-8547-E9AC27F6E17FQ47111118-51E59ED7-C665-4B08-A059-A425649AFC8DQ49275071-585092E1-81BB-4FEA-8FB7-B89FB95039F7Q53409926-F98C7154-D6BC-46B0-8495-671F8AC42C4B
P2860
Combination of the deacetylase inhibitor panobinostat and the multi-kinase inhibitor sorafenib for the treatment of metastatic hepatocellular carcinoma - review of the underlying molecular mechanisms and first case report.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Combination of the deacetylase ...... hanisms and first case report.
@ast
Combination of the deacetylase ...... hanisms and first case report.
@en
type
label
Combination of the deacetylase ...... hanisms and first case report.
@ast
Combination of the deacetylase ...... hanisms and first case report.
@en
prefLabel
Combination of the deacetylase ...... hanisms and first case report.
@ast
Combination of the deacetylase ...... hanisms and first case report.
@en
P2093
P2860
P356
P1433
P1476
Combination of the deacetylase ...... hanisms and first case report.
@en
P2093
Anette Pustowka
Deike Strobel
Matthias Ocker
Steffen Zopf
Susanne Gahr
Till Wissniowski
P2860
P304
P356
10.7150/JCA.4211
P577
2012-04-09T00:00:00Z